Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

InnovAge Holding (INNV) EBT: 2020-2025

Historic EBT for InnovAge Holding (INNV) over the last 6 years, with Q3 2025 value amounting to $7.9 million.

  • InnovAge Holding's EBT rose 24918.96% to $7.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$20.8 million, marking a year-over-year decrease of 2694.65%. This contributed to the annual value of -$34.0 million for FY2025, which is 5595.12% down from last year.
  • Per InnovAge Holding's latest filing, its EBT stood at $7.9 million for Q3 2025, which was up 24918.96% from -$4.2 million recorded in Q2 2025.
  • InnovAge Holding's EBT's 5-year high stood at $10.9 million during Q2 2021, with a 5-year trough of -$17.2 million in Q3 2022.
  • Its 5-year average for EBT is -$5.8 million, with a median of -$7.3 million in 2022.
  • Its EBT has fluctuated over the past 5 years, first tumbled by 68339.84% in 2022, then soared by 24918.96% in 2025.
  • Quarter analysis of 5 years shows InnovAge Holding's EBT stood at $2.3 million in 2021, then tumbled by 683.4% to -$13.5 million in 2022, then surged by 72.3% to -$3.7 million in 2023, then plummeted by 260.97% to -$13.5 million in 2024, then skyrocketed by 158.82% to $7.9 million in 2025.
  • Its last three reported values are $7.9 million in Q3 2025, -$4.2 million for Q2 2025, and -$11.1 million during Q1 2025.